Pricing Log in Create free account

Azitra, Inc. (AZTR) vs Xenetic Biosciences, Inc. (XBIO)

Azitra, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Azitra, Inc. and Xenetic Biosciences, Inc. are of similar size ($4.7M and $4.3M). Xenetic Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against 33.3%. Azitra, Inc. has the higher net margin (0.00% vs −75.9%) and the lower return on invested capital (−1,272.5% vs 0.00%). Across the 16 metrics below, Azitra, Inc. leads on 9 and Xenetic Biosciences, Inc. on 7.

Valuation

Metric AZTR XBIO Biotechnology median
P/E 1.05 n/m 8.50
P/S 2.33 1.39 9.71
P/B 0.18 0.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 0.30 0.64
EV/Sales (9.26) (0.24) 9.21
Earnings yield 95.57% (58.59%) (33.15%)
Free cash flow yield (842.70%) (50.87%) (25.50%)

Profitability

Metric AZTR XBIO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (256.67%) (47.05%) (56.36%)
Return on assets (190.69%) (40.17%) (48.04%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR XBIO Biotechnology median
Revenue growth (TTM) 58.18% 33.30% 6.02%
EPS growth (last fiscal year) 85.67% 38.52% 30.26%
Revenue growth, 5-year CAGR — 46.78% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 7.43 4.72
Net debt to EBITDA 0.20 2.78 0.96

Dividend

Metric AZTR XBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR XBIO Biotechnology median
Market cap 4.33m 4.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack